Haematological disorders, Guidance

MUS Webinar – Update on NICE VTE Management Guidance & Safer Use of Anticoagulation in Primary Care

14 October 2020In this webinar, Frances and Alison outlined important issues from World Thrombosis week and key points from the NICE VTE guidelines (NG158, March 2020) and…

Oral vitamin B12 – what are the prescribing considerations and what formulations are available?

29 June 2020This Medicines Q&A outlines what oral vitamin B12 (cyanocobalamin) preparations are available and associated prescribing considerations. Hydroxocobalamin 1mg administered intramuscularly (IM) is the preferred method…

Injectable medicines commonly used in primary care during COVID-19: Vitamin B12

13 May 2020This page summarises the advice of the British Society for Haematology on the administration of hydroxocobalamin (vitamin B12) injections during COVID-19 for patients already established…

How do I use CosmoFer (iron dextran) total dose infusion for correction of iron deficiency anaemia?

27 November 2019This updated Medicines Q&A provides guidance on the administration of Cosmofer (iron dextran) total dose infusion for the treatment of iron deficiency anaemia

Low molecular weight heparins – should prophylactic doses be used in patients with renal impairment?

23 October 2019This updated Medicines Q & A reviews the evidence available and considers when prophylactic doses of low molecular weight heparins can be used in patients…

What is the evidence for the use of Low Molecular Weight Heparins for the prophylaxis of travel-related thrombosis?

4 September 2018This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism

NOACs and Antidepressants – What are the risks of using these together and how should these risks be managed?

20 June 2018This article considers the risk of interactions between NOACs and antidepressants. ·        Non-vitamin K antagonist oral anticoagulants (NOACs) appear to have fewer clinically significant drug…